When is liver biopsy needed in the diagnosis of primary biliary cirrhosis?

BACKGROUND & AIMS Liver biopsy has been largely replaced by less invasive measurements applied to mathematical models in defining the prognosis of patients with primary biliary cirrhosis (PBC). The need for liver biopsy in the diagnosis of patients with positive antimitochondrial antibodies (AMAs) in the setting of biochemical cholestasis remains uncertain. This study was undertaken to determine which variables indicate the need for liver biopsy in patients with positive AMA and suspected PBC. METHODS A total of 3198 patients that were tested for AMA in 1999 and 2000 were identified. Of these, 198 (6.2%) were AMA positive. Forty-two patients were excluded because of unavailable laboratory data or liver biopsy specimens. Data on the remaining 156 patients were analyzed to determine which variables among patients with positive AMA with and without a histopathologic diagnosis of PBC indicate the need for liver biopsy. RESULTS In 131 of 156 (84.6%) patients, a diagnosis of PBC was established by liver biopsy. The histological diagnosis of PBC was associated with a cholestatic biochemical profile (alkaline phosphatase [AP] >1.5 times the upper limits of normal [ULN] and aspartate aminotransferase [AST] <5 times ULN) in 112 of 131 (85.5%) patients. The combination of AP >1.5 times the ULN and AST <5 times the ULN yielded a 98.2% positive predictive value of PBC diagnosis on liver biopsy in AMA-positive subjects. These results were corroborated by cross-validation in an independent set of patients. CONCLUSIONS In patients with positive AMA, a cholestatic biochemical profile (AP >1.5 times the ULN), and absence of markedly elevated AST (<5 times the ULN), liver biopsy is rarely required to establish the diagnosis of PBC. Liver biopsy would be beneficial to establish the diagnosis of PBC in only a minority of AMA-positive patients with AP <1.5 times the ULN or AST >5 times the ULN.

[1]  A. Tanaka,et al.  A case of autoimmune hepatitis with a high titer of antimitochondrial antibody and normal γ‐globulinemia , 2001, Journal of gastroenterology and hepatology.

[2]  T. Therneau,et al.  A model to predict survival in patients with end‐stage liver disease , 2001 .

[3]  H. Isomoto,et al.  Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirrhosis , 2001, Journal of gastroenterology and hepatology.

[4]  T M Therneau,et al.  Adaptation of the mayo primary biliary cirrhosis natural history model for application in liver transplant candidates , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  E. Heathcote.  Management of primary biliary cirrhosis , 2000 .

[6]  E. Dickson,et al.  Is routine cholangiography useful in men with suspected primary biliary cirrhosis? , 1999, Journal of clinical gastroenterology.

[7]  P. Scheuer.  Pathologic Features and Evolution of Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis , 1998 .

[8]  P. Scheuer,et al.  Ludwig Symposium on biliary disorders--part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. , 1998, Mayo Clinic proceedings.

[9]  David E. J. Jones,et al.  Natural history of early primary biliary cirrhosis , 1996, The Lancet.

[10]  K. Lindor,et al.  Outcome of Patients Hospitalized for Complications after Outpatient Liver Biopsy , 1993, Annals of Internal Medicine.

[11]  A. Eddleston,et al.  The Natural Course and Heterogeneity of Autoimmune-Type Chronic Active Hepatitis , 1991, Seminars in liver disease.

[12]  B J Ott,et al.  A 21-year experience with major hemorrhage after percutaneous liver biopsy. , 1990, Gastroenterology.

[13]  P. Grambsch,et al.  Prognosis in primary biliary cirrhosis: Model for decision making , 1989, Hepatology.

[14]  M. Kaplan,et al.  Primary Biliary Cirrhosis , 1987, The New England journal of medicine.

[15]  M. Bennett,et al.  Positive antimitochondrial antibody but normal alkaline phosphatase: Is this primary biliary cirrhosis? , 1986, Hepatology.

[16]  E. Eigenbrodt,et al.  Cat scratch disease: Report of a case with hepatic lesions and a brief review of the literature , 1985 .

[17]  J. Hermans,et al.  Clinical diagnosis of primary biliary cirrhosis: a classification based on major and minor criteria. , 1983, Hepato-gastroenterology.

[18]  H. Baum,et al.  SIGNIFICANCE OF ANTIMITOCHONDRIAL ANTIBODIES , 1981, The Lancet.

[19]  E. Dickson,et al.  Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis) , 1978, Virchows Archiv A.

[20]  S. Sherlock,et al.  The presentation and diagnosis of 100 patients with primary biliary cirrhosis. , 1973, The New England journal of medicine.

[21]  M. Colombo,et al.  Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. , 1986, Journal of hepatology.